Related Experiment Video
Updated: Jul 20, 2026

A Modified Yeast-one Hybrid System for Heteromeric Protein Complex-DNA Interaction Studies
Published on: July 24, 2017
A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization
Gal Bitan1, Bogdan Tarus, Sabrina S Vollers
1Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.
Abstract:
Aberrant protein oligomerization is an important pathogenetic process in vivo. In Alzheimer's disease (AD), the amyloid beta-protein (Abeta) forms neurotoxic oligomers. The predominant in vivo Abeta alloforms, Abeta40 and Abeta42, have distinct oligomerization pathways. Abeta42 monomers oligomerize into pentamer/hexamer units (paranuclei) which self-associate to form larger oligomers. Abeta40 does not form these paranuclei, a fact which may explain the particularly strong linkage of Abeta42 with AD. Here, we sought to determine the structural elements controlling paranucleus formation as a first step toward the development of strategies for treating AD. Because oxidation of Met(35) is associated with altered Abeta assembly, we examined the role of Met(35) in controlling Abeta oligomerization. Oxidation of Met(35) in Abeta42 blocked paranucleus formation and produced oligomers indistinguishable in size and morphology from those produced by Abeta40. Systematic structural alterations of the C(gamma)(35)-substituent group revealed that its electronic nature, rather than its size (van der Waals volume), was the factor controlling oligomerization pathway choice. Preventing assembly of toxic Abeta42 paranuclei through selective oxidation of Met(35) thus represents a potential therapeutic approach for AD.
Insights
Oxidizing methionine-35 in amyloid beta-42 (Abeta42) prevents toxic paranuclei formation, a key step in Alzheimer
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Aberrant protein oligomerization, particularly amyloid beta-protein (Abeta) in Alzheimer's disease (AD), drives neurotoxicity.
- Amyloid beta-42 (Abeta42) forms distinct toxic oligomers (paranuclei) compared to Abeta40, correlating with AD pathogenesis.
Purpose of the Study:
- To identify structural elements governing Abeta42 paranucleus formation.
- To explore Met(35) oxidation as a strategy to inhibit toxic Abeta42 oligomerization for AD treatment.
Main Methods:
- Investigated the role of methionine-35 (Met(35)) in Abeta42 oligomerization.
- Systematically altered the C(gamma)(35)-substituent group of Abeta42.
- Analyzed oligomer size and morphology.
Main Results:
- Oxidation of Met(35) in Abeta42 blocked paranucleus formation.
- Oxidized Abeta42 produced oligomers similar to Abeta40.
- Electronic properties of the C(gamma)(35)-substituent, not size, controlled oligomerization pathway.
Conclusions:
- Selective Met(35) oxidation inhibits toxic Abeta42 paranuclei assembly.
- This targeted oxidation presents a potential therapeutic strategy for Alzheimer's disease.
More Related Videos
10:01Combining Chemical Cross-linking and Mass Spectrometry of Intact Protein Complexes to Study the Architecture of Multi-subunit Protein Assemblies
Published on: November 28, 2017
09:37Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
Published on: May 2, 2019
Related Concept Videos
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Tagging and Fusion Proteins